Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.
Borel C, Sun XS, Coutte A, Bera G, Sire C, Zanetta S, Alfonsi M, Janoray G, Chatellier T, Garcia-Ramirez M, Gherga E, Hammoud Y, Burgy M, Etienne-Selloum N, Pechery A, Girard-Calais MH, Velten M, Pignon JP, Wanneveich M, Bourhis J. Borel C, et al. Among authors: coutte a. Radiother Oncol. 2024 May 19;197:110329. doi: 10.1016/j.radonc.2024.110329. Online ahead of print. Radiother Oncol. 2024. PMID: 38768714 Free article.
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Guigay J, Le Caer H, Ferrand FR, Geoffrois L, Saada-Bouzid E, Fayette J, Sire C, Cupissol D, Blot E, Guillet P, Pavillet J, Bozec L, Capitain O, Rolland F, Debourdeau P, Pointreau Y, Falandry C, Lopez S, Coutte A, Chatellier T, Dalloz P, Ortholan C, Michel C, Lacas B, Cheurfa N, Schwob D, Bourhis J, Mertens C, Aupérin A; ELAN Group including Gustave Roussy, Unicancer GERICO and H&N groups, and GORTEC. Guigay J, et al. Among authors: coutte a. Lancet Healthy Longev. 2024 Jun;5(6):e392-e405. doi: 10.1016/S2666-7568(24)00048-5. Epub 2024 May 14. Lancet Healthy Longev. 2024. PMID: 38759667 Free article. Clinical Trial.
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus Initiative.
Basse C, Khalifa J, Thillays F, Le Pechoux C, Maury JM, Bonte PE, Coutte A, Pourel N, Bourbonne V, Pradier O, Belliere A, Le Tinier F, Deberne M, Tanguy R, Denis F, Padovani L, Zaccariotto A, Molina T, Chalabreysse L, Brioude G, Delatour B, Faivre JC, Cao K, Giraud P, Riet FG, Thureau S, Antoni D, Massabeau C, Keller A, Bonnet E, Lerouge D, Martin E, Girard N, Botticella A. Basse C, et al. Among authors: coutte a. J Thorac Oncol. 2024 Apr 10:S1556-0864(24)00161-8. doi: 10.1016/j.jtho.2024.04.003. Online ahead of print. J Thorac Oncol. 2024. PMID: 38608932
[Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers].
Guillemin F, Blanchard P, Boisselier P, Brahimi Y, Calugaru V, Coutte A, Gillon P, Graff P, Liem X, Modesto A, Pointreau Y, Racadot S, Sun XS, Bellini R, Pham Dang N, Saroul N, Bourhis J, Thariat J, Biau J, Lapeyre M. Guillemin F, et al. Among authors: coutte a. Cancer Radiother. 2024 Apr;28(2):218-227. doi: 10.1016/j.canrad.2023.12.001. Epub 2024 Apr 9. Cancer Radiother. 2024. PMID: 38599940 French.
Characterization of a Molecularly Distinct Subset of Oncocytic Pleomorphic Adenomas/Myoepitheliomas Harboring Recurrent ZBTB47-AS1::PLAG1 Gene Fusion.
Alsugair Z, Perrot J, Descotes F, Lopez J, Champagnac A, Pissaloux D, Castain C, Onea M, Céruse P, Philouze P, Lépine C, Lanic MD, Laé M, Costes-Martineau V, Benzerdjeb N; and REFCOR Members. Alsugair Z, et al. Am J Surg Pathol. 2024 May 1;48(5):551-561. doi: 10.1097/PAS.0000000000002206. Epub 2024 Mar 18. Am J Surg Pathol. 2024. PMID: 38497430
[Five-fraction radiotherapy for breast cancer].
Dworczak M, Bielinyte G, Coutte A, Mirabel X, Lartigau É, Lemoine P, Rivera S, Pasquier D. Dworczak M, et al. Among authors: coutte a. Cancer Radiother. 2023 Sep;27(6-7):531-534. doi: 10.1016/j.canrad.2023.07.004. Epub 2023 Aug 1. Cancer Radiother. 2023. PMID: 37537026 French.
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.
Martz N, Salleron J, Dhermain F, Vogin G, Daisne JF, Mouttet-Audouard R, Tanguy R, Noel G, Peyre M, Lecouillard I, Jacob J, Attal J, Charissoux M, Veresezan O, Hanzen C, Huchet A, Latorzeff I, Coutte A, Doyen J, Stefan D, Feuvret L, Garcia GCTE, Royer P. Martz N, et al. Among authors: coutte a. Radiat Oncol. 2023 Jul 5;18(1):113. doi: 10.1186/s13014-023-02300-w. Radiat Oncol. 2023. PMID: 37408055 Free PMC article. Review.
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
Thomas-Joulié A, Houillier C, Antoni D, Créhange G, Jouglar E, Colin P, Benchalal M, Lang P, Alfonsi M, Hamidou H, Coutte A, Ahrweiller F, Dadoun N, Pointreau Y, Ammarguellat H, Bernier-Chastagner V, Belkacemi Y, Vieillot S, Hoang-Xuan K, Soussain C, Jacob J, Feuvret L. Thomas-Joulié A, et al. Among authors: coutte a. Acta Oncol. 2023 Jun;62(6):648-656. doi: 10.1080/0284186X.2023.2225146. Epub 2023 Jun 20. Acta Oncol. 2023. PMID: 37338525
54 results